Central Nervous System- MoA Flashcards
Dopaminergics
Increased dopamine synthesis and dopaminergic function
Dopa-decarboxylase inhibitors
Stops breakdown of Levadopa in the periphery by inhibiting dopa-decarboxylase
Inhibitors of Monoamine Oxidase B (MAOI)
Inhibition of dopamine breakdown
Inhibitor of COMT (catechol-O-methyl transferase)
Blockade of dopamine precursor breakdown by inhibition of COMT
Anticholinergics
Blockade of acetylcholine function
Muscarinic cholinergic receptor antagonist
Dopamine-depleting drugs
Blocks VMAT, preventing uptake of DA into vesicles
Selective serotonin reuptake inhibitors (SSRIs)
Inhibition of serotonin (5HT) reuptake pump in synaptic cleft
Reversible Inhibitor of Monoamine Oxidase type A (RIMA)
Inhibits monoamine oxidase A, preferentially decreases breakdown of serotonin and noradrenaline
Tricyclic antidepressants (TCAs)
Inhibition of noradrenaline and serotonin reuptake in synaptic cleft, H1 antagonist, M1 antagonist, adrenergic antagonist
Atypical antidepressants
5-HT1A partial agonist (Busprione)
Noradrenaline reuptake inhibitor (Venlafaxine, Reboxetine)
Noradrenaline /Dopamine reuptake inhibitor (Buproprion)
Melatonin agonist (Agomelatine)
Alpha-2 antagonist (Mirtazepine)
Antipsychotics- Classical (also known as First Generation)
Selective D2 dopamine receptor blockade
Antipsychotics- Atypical (also known as Second Generation)
Selective D2 dopamine and 5-HT receptor blockade
Mood Stabiliser
Neuronal calcium channel blockade
Unclear – possible neuronal calcium channel blockade
Cholinesterase inhibitors
Inhibition of acetylcholinesterase (reversible)
NMDA receptor antagonist
VD blocker of NDMA receptors